You just read:

AcelRx Pharmaceutical's pooled safety results for sufentanil sublingual tablets (DSUVIA) selected for presentation at 44th Annual Regional Anesthesiology & Acute Pain Medicine Meeting

News provided by

AcelRx Pharmaceuticals, Inc.

Apr 11, 2019, 16:37 ET